Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin + Pemetrexed + Avastin in Advanced Non-Squamous NSCLC
NCT00998166Phase 2Terminated
- Sponsor
- Columbia University
- Start
- Jun 2009
- Primary completion
- Oct 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in non-small cell lung cancer (NSCLC), sponsored by Columbia University. Started Jun 2009; status: terminated.
02
Drugs
bevacizumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00998166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00998166.